Cisplatin-based combination chemotherapy
WebCurrently, the standard first-line chemotherapy regimen is systemic administration of platinum-based chemotherapy combined with a taxane. A major problem besides cisplatin resistance (occurring in nearly one-third of patients) … WebSep 21, 2016 · Cisplatin-based chemotherapy during pelvic radiation therapy improves long-term PFS and OS among locally advanced cervical cancer patients collectively and …
Cisplatin-based combination chemotherapy
Did you know?
WebCisplatin is a chemotherapy drug. You might have it as a treatment for a number of different types of cancer. You might have cisplatin on its own or in combination with other … WebCisplatin-based chemotherapy (CBC) is highly efficacious for advanced cervical cancer; its efficacy can be enhanced by combining with 15 mg/kg (standard dose) bevacizumab (BEV). However, this standard dose is associated with various adverse events (AEs).
WebCisplatin based combination therapy can in these indications prolong the survival in 30-40% of patients. The role of carboplatin in malignant lymphoma is not clear yet and is … WebIn this network meta-analysis, we found that patients who received a triple combination of platinum-based chemotherapy reported more hematological complications such as anemia and thrombocytopenia but provided relatively higher PFS and OS. In our study, all patients were sensitive to platinum-based chemotherapy during the first-line treatment.
WebBackground and Methods. On behalf of the Gynecologic Oncology Group, we performed a randomized trial of radiotherapy in combination with three concurrent chemotherapy … WebDec 11, 2024 · Currently, the standard antiemetic therapy for cisplatin—a highly emetogenic chemotherapy agent—involves triplet-combination therapy with a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist, neurokinin-1 (NK1) receptor antagonist, and dexamethasone.
WebSep 3, 2015 · Introduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A common side effect of multiday cisplatin chemotherapy is severe nausea and vomiting. Considerable progress has been made in the control of these side effects since the introduction of cisplatin based chemotherapy in the 1970s.
WebOct 17, 2012 · Combination cisplatin-based chemotherapy could be a viable option for patients of good performance status with recurrent/metastatic cervical cancer, but further trials that report adequate survival and QoL data are sought. Response rates and improvements in survival are low. Cisplatin-based combinat … porch flooring tongue and groove pvcWebChemotherapy consisted of cisplatin-based combination treatment and radiotherapy was given as whole-brain irradiation of 30 to 40 Gy and in single cases combined with a boost of 10 Gy to single lesions. Results: Overall, 10 patients achieved long-term survival (23%; 95% confidence interval [CI], 10.1% to 35.4%). porch floor ideasWebJul 1, 2007 · Conclusion: Cisplatin-based chemotherapy during pelvic radiation therapy improves long-term PFS and OS among locally advanced cervical cancer patients … porch floor paintersWebIntroduction of cisplatin based chemotherapy has revolutionized the treatment of germ cell tumors. A common side effect of multiday cisplatin chemotherapy is severe nausea and vomiting. Considerable progress has been made in the control of these side effects since the introduction of cisplatin based chemotherapy in the 1970s. sharon white john lewis twitterWebFeb 22, 2024 · Combination chemotherapy is the use of more than one medication at a time to treat cancer. Since chemotherapy drugs affect cancer cells at different points in … sharon whitehurst-payne san diegohttp://referentiels-aristot.com/wp-content/uploads/08_Soins-de-Support_2024_prise-en-charge-nutritionnelle-moyen-prise-en-charge.pdf sharon white bornWeb1 day ago · Metabolites of melatonin can also serve protective roles against DNA damage, but while combined with chemotherapeutic agents, including doxorubicin, cytarabine, daunorubicin, and etoposide, melatonin exerts a synergistic effect on inducing cytotoxicity and apoptosis in cancer cells [26]. Table 2. Chemotherapy related MMR mutations sharon white contact details john lewis